{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:41:20Z","timestamp":1792428080121,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIHR i4i Challenge study.","award":["NIHR202161"],"award-info":[{"award-number":["NIHR202161"]}]},{"name":"NIHR i4i Challenge study","award":["NIHR202161"],"award-info":[{"award-number":["NIHR202161"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Whole-body MRI (WB-MRI) is increasingly used for early diagnosis, cancer staging and treatment monitoring, but adoption remains sub-optimal. The aim of this scoping review was to map research on patient and provider perspectives of WB-MRI in oncology, and identify methodological limitations and evidence gaps. The review followed the JBI methodological framework and the PRISMA-ScR checklist. Five electronic databases were searched from inception to 29th March 2025: Cochrane Library, PubMed, APA PsycINFO, APA Psych Articles, and Academic Search Complete. Screening, data extraction, and quality assessment were performed by two authors independently, using COVIDENCE software, with results summarized via narrative synthesis. Twenty-eight studies met eligibility criteria, covering four distinct populations: general population (n = 8), people with cancer pre-disposition syndromes (n = 7), or suspected or confirmed cancer (n = 10), and radiologists (n = 3). Few studies examined beliefs about WB-MRI. Limited evidence shows awareness of WB-MRI attributes, such as the absence of ionising radiation, predicts preferences among cancer patients. Research on radiologists shows low levels of WB-MRI adoption in the USA and UK, attributed to limited scanner availability and a lack of trained radiologists. Among patients, uptake is modest (60%) in both population cohort studies and those recommended for surveillance, but the role of scan beliefs in predicting uptake has not been explored. Undergoing WB-MRI, or being notified of incidental findings, does not appear to cause adverse psychological consequences, but cancer specific concerns were not always assessed and research not always adequately powered. Evidence of provider and patient perspectives towards WB-MRI is limited and of varying quality. The development of validated measures examining WB-MRI beliefs and experience would enhance research and facilitate future data synthesis.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical trial number<\/jats:bold>\n                    Not applicable.\n                  <\/jats:p>","DOI":"10.1186\/s40644-026-01093-x","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:48:11Z","timestamp":1784800091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Provider and patient perceptions on the usage of whole-body magnetic resonance imaging in oncology: a scoping review"],"prefix":"10.1186","volume":"26","author":[{"given":"Nazm","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"110099","DOI":"10.1016\/j.clinimag.2024.110099","volume":"108","author":"SS Vulasala","year":"2024","unstructured":"Vulasala SS, Virarkar M, Karbasian N, Calimano-Ramirez LF, Daoud T, Amini B, et al. Whole-body MRI in oncology: A comprehensive review. Clin Imaging. 2024;108:110099.","journal-title":"Clin Imaging"},{"issue":"2","key":"1093_CR2","first-page":"345","volume":"279","author":"FE Lecouvet","year":"2016","unstructured":"Lecouvet FE, Whole-Body MR, Imaging. Musculoskelet Appl Radiol. 2016;279(2):345\u201365.","journal-title":"Musculoskelet Appl Radiol"},{"issue":"12","key":"1093_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/01.rli.0000185878.61270.b0","volume":"40","author":"GP Schmidt","year":"2005","unstructured":"Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol. 2005;40(12):743\u201353.","journal-title":"Invest Radiol"},{"issue":"12","key":"1093_CR4","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1007\/s00330-013-2968-x","volume":"23","author":"G Petralia","year":"2013","unstructured":"Petralia G, Padhani A, Summers P, Alessi S, Raimondi S, Testori A, et al. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients? Eur Radiol. 2013;23(12):3466\u201376.","journal-title":"Eur Radiol"},{"key":"1093_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.breast.2017.07.014","volume":"35","author":"FA Peccatori","year":"2017","unstructured":"Peccatori FA, Codacci-Pisanelli G, Del Grande M, Scarfone G, Zugni F, Petralia G. Whole body MRI for systemic staging of breast cancer in pregnant women. Breast. 2017;35:177\u201381.","journal-title":"Breast"},{"issue":"3","key":"1093_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00432-016-2288-z","volume":"143","author":"T Liu","year":"2017","unstructured":"Liu T, Wang S, Liu H, Meng B, Zhou F, He F, et al. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT. J Cancer Res Clin Oncol. 2017;143(3):457\u201365.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"1093_CR7","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","volume":"21","author":"HL Yang","year":"2011","unstructured":"Yang HL, Liu T, Wang XM, Xu Y, Deng SM. Diagnosis of bone metastases: a meta-analysis comparing (1)(8)FDG PET, CT, MRI and bone scintigraphy. Eur Radiol. 2011;21(12):2604\u201317.","journal-title":"Eur Radiol"},{"issue":"5","key":"1093_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/jmri.20895","volume":"25","author":"RC Semelka","year":"2007","unstructured":"Semelka RC, Armao DM, Elias J Jr., Huda W. Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging. 2007;25(5):900\u20139.","journal-title":"J Magn Reson Imaging"},{"issue":"17","key":"1093_CR9","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.19.02757","volume":"38","author":"EJ Trabulsi","year":"2020","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, et al. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. 2020;38(17):1963\u201396.","journal-title":"J Clin Oncol"},{"key":"1093_CR10","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Nakanishi K, Ueda T, Nakazawa T, Oshima K. Retrospective comparative study between 3T WB-MRI including WB-DWI and 18F-FDG-PET\/CT in detection of metastatic disease. Cancer Rep Rev. 2017;1.","DOI":"10.15761\/CRR.1000135"},{"issue":"3","key":"1093_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1001-9294(09)60037-7","volume":"23","author":"TH Yang","year":"2008","unstructured":"Yang TH, Lin JZ, Wang X, Lu JH, Chen Z. Preliminary study of feasibility of whole body diffusion weighted imaging in diagnosis of metastasis of tumor. Chin Med Sci J. 2008;23(3):187\u201392.","journal-title":"Chin Med Sci J"},{"issue":"1","key":"1093_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11547-008-0348-4","volume":"114","author":"A Stecco","year":"2009","unstructured":"Stecco A, Romano G, Negru M, Volpe D, Saponaro A, Costantino S, et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med. 2009;114(1):1\u201317.","journal-title":"Radiol Med"},{"issue":"1","key":"1093_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejrad.2009.01.037","volume":"74","author":"S Krohmer","year":"2010","unstructured":"Krohmer S, Sorge I, Krausse A, Kluge R, Bierbach U, Marwede D, et al. Whole-body MRI for primary evaluation of malignant disease in children. Eur J Radiol. 2010;74(1):256\u201361.","journal-title":"Eur J Radiol"},{"key":"1093_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.critrevonc.2018.02.012","volume":"124","author":"J Gariani","year":"2018","unstructured":"Gariani J, Westerland O, Natas S, Verma H, Cook G, Goh V. Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or (18)F-fluorodeoxyglucose positron emission tomography\/CT ((18)F-FDG PET\/CT) in patients with myeloma: Systematic review of diagnostic performance. Crit Rev Oncol Hematol. 2018;124:66\u201372.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"980","key":"1093_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1259\/bjr\/52773262","volume":"82","author":"SA Sohaib","year":"2009","unstructured":"Sohaib SA, Cook G, Allen SD, Hughes M, Eisen T, Gore M. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer. Br J Radiol. 2009;82(980):632\u20139.","journal-title":"Br J Radiol"},{"issue":"1","key":"1093_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00330-003-1968-7","volume":"14","author":"K Engelhard","year":"2004","unstructured":"Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol. 2004;14(1):99\u2013105.","journal-title":"Eur Radiol"},{"issue":"8","key":"1093_CR17","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1007\/s00259-020-05182-2","volume":"48","author":"O Westerland","year":"2021","unstructured":"Westerland O, Amlani A, Kelly-Morland C, Fraczek M, Bailey K, Gleeson M, et al. Comparison of the diagnostic performance and impact on management of 18F-FDG PET\/CT and whole-body MRI in multiple myeloma. Eur J Nucl Med Mol Imaging. 2021;48(8):2558\u201365.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1093_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1471-2407-11-242","volume":"11","author":"NY Wu","year":"2011","unstructured":"Wu NY, Cheng HC, Ko JS, Cheng YC, Lin PW, Lin WC, et al. Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals. BMC Cancer. 2011;11:242.","journal-title":"BMC Cancer"},{"issue":"7","key":"1093_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(19)30056-1","volume":"4","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Beare S, Bhatnagar G, Blunt D, Boavida P, et al. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. Lancet Gastroenterol Hepatol. 2019;4(7):529\u201337.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"1093_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S2213-2600(19)30090-6","volume":"7","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Ball S, Beare S, Bhatnagar G, Bhowmik A, et al. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. Lancet Respir Med. 2019;7(6):523\u201332.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"1093_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","volume":"17","author":"A Villani","year":"2016","unstructured":"Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 2016;17(9):1295\u2013305.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1093_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","volume":"12","author":"A Villani","year":"2011","unstructured":"Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 2011;12(6):559\u201367.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1093_CR23","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","volume":"3","author":"ML Ballinger","year":"2017","unstructured":"Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, et al. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. JAMA Oncol. 2017;3(12):1634\u20139.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1093_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol. 2015;33(6):657\u201364.","journal-title":"J Clin Oncol"},{"key":"1093_CR25","unstructured":"National Institute for Health and Care Excellence. Myeloma: diagnosis and management. 2018. https:\/\/www.nice.org.uk\/guidance\/ng35\/resources\/myeloma-diagnosis-and-management-pdf-1837394042821"},{"issue":"1","key":"1093_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40644-020-00315-0","volume":"20","author":"F Zugni","year":"2020","unstructured":"Zugni F, Padhani AR, Koh DM, Summers PE, Bellomi M, Petralia G. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations. Cancer Imaging. 2020;20(1):34.","journal-title":"Cancer Imaging"},{"issue":"11","key":"1093_CR27","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC, et al. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2017;23(11):e38\u201345.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1093_CR28","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00330-025-11976-5","volume":"36","author":"J Martins da Fonseca","year":"2026","unstructured":"Martins da Fonseca J, Trennepohl T, Pinheiro LG, Carra Forte G, Campello CA, Altmayer S, et al. Whole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis. Eur Radiol. 2026;36(3):1813\u201323.","journal-title":"Eur Radiol"},{"issue":"2","key":"1093_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jmri.29461","volume":"61","author":"L Conti","year":"2025","unstructured":"Conti L, Mazzoni D, Marzorati C, Grasso R, Busacchio D, Petralia G, et al. Observations Regarding the Detection of Abnormal Findings Following a Cancer Screening Whole-Body MRI in Asymptomatic Subjects: The Psychological Consequences and the Role of Personality Traits Over Time. J Magn Reson Imaging. 2025;61(2):634\u201345.","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"1093_CR30","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00256-024-04723-2","volume":"53","author":"FE Lecouvet","year":"2024","unstructured":"Lecouvet FE, Chabot C, Taihi L, Kirchgesner T, Triqueneaux P, Malghem J. Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it. Skeletal Radiol. 2024;53(9):1815\u201331.","journal-title":"Skeletal Radiol"},{"issue":"1","key":"1093_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, et al. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology. 2019;291(1):5\u201313.","journal-title":"Radiology"},{"key":"1093_CR32","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3332\/ecancer.2021.1164","volume":"15","author":"P Summers","year":"2021","unstructured":"Summers P, Saia G, Colombo A, Pricolo P, Zugni F, Alessi S, et al. Whole-body magnetic resonance imaging: technique, guidelines and key applications. Ecancermedicalscience. 2021;15:1164.","journal-title":"Ecancermedicalscience"},{"key":"1093_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clinimag.2018.08.004","volume":"52","author":"S Oliveri","year":"2018","unstructured":"Oliveri S, Pricolo P, Pizzoli S, Faccio F, Lampis V, Summers P, et al. Investigating cancer patient acceptance of Whole Body MRI. Clin Imaging. 2018;52:246\u201351.","journal-title":"Clin Imaging"},{"issue":"9","key":"1093_CR34","doi-asserted-by":"publisher","first-page":"e016391","DOI":"10.1136\/bmjopen-2017-016391","volume":"7","author":"R Evans","year":"2017","unstructured":"Evans R, Taylor S, Janes S, Halligan S, Morton A, Navani N, et al. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study. BMJ Open. 2017;7(9):e016391.","journal-title":"BMJ Open"},{"issue":"1086","key":"1093_CR35","doi-asserted-by":"publisher","first-page":"20170731","DOI":"10.1259\/bjr.20170731","volume":"91","author":"RE Evans","year":"2018","unstructured":"Evans RE, Taylor SA, Beare S, Halligan S, Morton A, Oliver A, et al. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations. Br J Radiol. 2018;91(1086):20170731.","journal-title":"Br J Radiol"},{"issue":"2","key":"1093_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1748-720X.2008.00266.x","volume":"36","author":"SM Wolf","year":"2008","unstructured":"Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36(2):219\u201348.","journal-title":"J Law Med Ethics"},{"issue":"4","key":"1093_CR37","doi-asserted-by":"publisher","first-page":"953","DOI":"10.11124\/JBIES-21-00242","volume":"20","author":"MDJ Peters","year":"2022","unstructured":"Peters MDJ, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953\u201368.","journal-title":"JBI Evid Synth"},{"issue":"7","key":"1093_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"1093_CR39","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. JBI manual for evidence synthesis. 2024.","DOI":"10.46658\/JBIMES-24-01"},{"issue":"1","key":"1093_CR40","first-page":"7","volume":"7","author":"LL Ma","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.","journal-title":"Mil Med Res"},{"key":"1093_CR41","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"1118","key":"1093_CR42","doi-asserted-by":"publisher","first-page":"20191031","DOI":"10.1259\/bjr.20191031","volume":"94","author":"D Busacchio","year":"2021","unstructured":"Busacchio D, Mazzocco K, Gandini S, Pricolo P, Masiero M, Summers PE, et al. Preliminary observations regarding the expectations, acceptability and satisfaction of whole-body MRI in self-referring asymptomatic subjects. Br J Radiol. 2021;94(1118):20191031.","journal-title":"Br J Radiol"},{"issue":"2","key":"1093_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/13548506.2022.2126989","volume":"28","author":"D Busacchio","year":"2023","unstructured":"Busacchio D, Mazzoni D, Mazzocco K, Pricolo P, Summers PE, Petralia G, et al. Psychological characteristics and satisfaction for the whole-body MRI in cancer screening. Psychol Health Med. 2023;28(2):548\u201354.","journal-title":"Psychol Health Med"},{"issue":"11","key":"1093_CR44","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1007\/s00330-019-06077-z","volume":"29","author":"P Hegedus","year":"2019","unstructured":"Hegedus P, von Stackelberg O, Neumann C, Selder S, Werner N, Erdmann P, et al. How to report incidental findings from population whole-body MRI: view of participants of the German National Cohort. Eur Radiol. 2019;29(11):5873\u20138.","journal-title":"Eur Radiol"},{"key":"1093_CR45","doi-asserted-by":"crossref","unstructured":"Korbmacher-Bottcher D, Bamberg F, Peters A, Linkohr B, Ladwig KH, Schwettmann L et al. Long-Term psychosocial consequences of whole-body magnetic resonance imaging and reporting of incidental findings in a population-based cohort study. Diagnostics (Basel). 2022;12(10).","DOI":"10.3390\/diagnostics12102356"},{"key":"1093_CR46","doi-asserted-by":"publisher","first-page":"109451","DOI":"10.1016\/j.ejrad.2020.109451","volume":"134","author":"CL Schlett","year":"2021","unstructured":"Schlett CL, Rospleszcz S, Korbmacher D, Lorbeer R, Auweter S, Hetterich H, et al. Incidental findings in whole-body MR imaging of a population-based cohort study: Frequency, management and psychosocial consequences. Eur J Radiol. 2021;134:109451.","journal-title":"Eur J Radiol"},{"issue":"5","key":"1093_CR47","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00330-012-2723-8","volume":"23","author":"CO Schmidt","year":"2013","unstructured":"Schmidt CO, Hegenscheid K, Erdmann P, Kohlmann T, Langanke M, Volzke H, et al. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study. Eur Radiol. 2013;23(5):1343\u201351.","journal-title":"Eur Radiol"},{"issue":"1","key":"1093_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10654-015-0101-y","volume":"31","author":"CO Schmidt","year":"2016","unstructured":"Schmidt CO, Sierocinski E, Hegenscheid K, Baumeister SE, Grabe HJ, Volzke H. Impact of whole-body MRI in a general population study. Eur J Epidemiol. 2016;31(1):31\u20139.","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"1093_CR49","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/gim.2017.8","volume":"19","author":"J Ross","year":"2017","unstructured":"Ross J, Bojadzieva J, Peterson S, Noblin SJ, Yzquierdo R, Askins M, et al. The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome. Genet Med. 2017;19(9):1064\u201370.","journal-title":"Genet Med"},{"issue":"4","key":"1093_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jmedgenet-2019-106407","volume":"57","author":"EK Bancroft","year":"2020","unstructured":"Bancroft EK, Saya S, Brown E, Thomas S, Taylor N, Rothwell J, et al. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY). J Med Genet. 2020;57(4):226\u201336.","journal-title":"J Med Genet"},{"issue":"3","key":"1093_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10689-016-9964-7","volume":"16","author":"KA McBride","year":"2017","unstructured":"McBride KA, Ballinger ML, Schlub TE, Young MA, Tattersall MHN, Kirk J, et al. Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? Fam Cancer. 2017;16(3):423\u201332.","journal-title":"Fam Cancer"},{"issue":"3","key":"1093_CR52","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/hex.13756","volume":"26","author":"R Neves","year":"2023","unstructured":"Neves R, Perez BD, Tindall T, Fernandez NS, Panek R, Wilne S, et al. Whole-body MRI for cancer surveillance in ataxia-telangiectasia: A qualitative study of the perspectives of people affected by A-T and their families. Health Expect. 2023;26(3):1358\u201367.","journal-title":"Health Expect"},{"issue":"6","key":"1093_CR53","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/cncr.34631","volume":"129","author":"M Omran","year":"2023","unstructured":"Omran M, Johansson H, Lundgren C, Silander G, Stenmark-Askmalm M, Loman N, et al. Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study. Cancer. 2023;129(6):946\u201355.","journal-title":"Cancer"},{"key":"1093_CR54","doi-asserted-by":"publisher","first-page":"e2400642","DOI":"10.1200\/PO-24-00642","volume":"9","author":"FVF Que","year":"2025","unstructured":"Que FVF, Ishak NDB, Li ST, Yuen J, Shaw T, Goh HX, et al. Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective Study. JCO Precis Oncol. 2025;9:e2400642.","journal-title":"JCO Precis Oncol"},{"issue":"17","key":"1093_CR55","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1002\/cncr.33004","volume":"126","author":"N Rippinger","year":"2020","unstructured":"Rippinger N, Fischer C, Haun MW, Rhiem K, Grill S, Kiechle M, et al. Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance survey. Cancer. 2020;126(17):4032\u201341.","journal-title":"Cancer"},{"issue":"1","key":"1093_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejrad.2013.10.008","volume":"83","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, Vermoolen MA, Ludwig I, Bierings MB, Nievelstein RA. Whole-body MRI vs. CT for staging lymphoma: patient experience. Eur J Radiol. 2014;83(1):163\u20136.","journal-title":"Eur J Radiol"},{"issue":"9","key":"1093_CR57","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1177\/0284185117751280","volume":"59","author":"E Dyrberg","year":"2018","unstructured":"Dyrberg E, Larsen EL, Hendel HW, Thomsen HS. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET\/CT, choline-PET\/CT, whole-body MRI, and bone SPECT\/CT. Acta Radiol. 2018;59(9):1119\u201325.","journal-title":"Acta Radiol"},{"issue":"3","key":"1093_CR58","first-page":"e1737","volume":"6","author":"K Mazzocco","year":"2023","unstructured":"Mazzocco K, Busacchio D, Summers PE, Marzorati C, Pricolo P, Petralia G, et al. Is whole-body magnetic resonance imaging a source of anxiety in oncological patients? Cancer Rep (Hoboken). 2023;6(3):e1737.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"7","key":"1093_CR59","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1007\/s00330-019-06153-4","volume":"29","author":"A Miles","year":"2019","unstructured":"Miles A, Taylor SA, Evans REC, Halligan S, Beare S, Bridgewater J, et al. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment. Eur Radiol. 2019;29(7):3889\u2013900.","journal-title":"Eur Radiol"},{"issue":"4","key":"1093_CR60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/1754-9485.13038","volume":"64","author":"A Miles","year":"2020","unstructured":"Miles A, Evans RE, Halligan S, Beare S, Bridgewater J, Goh V, et al. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT\/ PET-CT for staging colorectal or lung cancer. J Med Imaging Radiat Oncol. 2020;64(4):537\u201345.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"1093_CR61","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/ijgc-2023-005264","volume":"34","author":"P Pinto","year":"2024","unstructured":"Pinto P, Valentin L, Borcinova M, Wiesnerova M, Filip F, Burgetova A, et al. Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey. Int J Gynecol Cancer. 2024;34(6):871\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"1160","key":"1093_CR62","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/bjr\/tqae110","volume":"97","author":"SCM Quinn","year":"2024","unstructured":"Quinn SCM, Goh V, Westerland OA, Pratt G. National myeloma patient survey shows continuing inappropriate imaging and geographical inequalities. Br J Radiol. 2024;97(1160):1443\u20139.","journal-title":"Br J Radiol"},{"issue":"11","key":"1093_CR63","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00256-020-03471-3","volume":"49","author":"JM Feldhaus","year":"2020","unstructured":"Feldhaus JM, Garner HW, Wessell DE. Society of skeletal radiology member utilization and performance of whole-body MRI in adults. Skeletal Radiol. 2020;49(11):1731\u20136.","journal-title":"Skeletal Radiol"},{"issue":"1092","key":"1093_CR64","doi-asserted-by":"publisher","first-page":"20180462","DOI":"10.1259\/bjr.20180462","volume":"91","author":"OA Westerland","year":"2018","unstructured":"Westerland OA, Pratt G, Kazmi M, El-Najjar I, Streetly M, Yong K, et al. National survey of imaging practice for suspected or confirmed plasma cell malignancies. Br J Radiol. 2018;91(1092):20180462.","journal-title":"Br J Radiol"},{"issue":"11","key":"1093_CR65","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.crad.2021.05.019","volume":"76","author":"O Westerland","year":"2021","unstructured":"Westerland O, Drinkwater KJ, Parikh J, Streetly M, Pratt G, Goh V, et al. Imaging in myeloma: a Royal College of Radiologists national survey of current imaging practice. Clin Radiol. 2021;76(11):820\u20138.","journal-title":"Clin Radiol"},{"issue":"9","key":"1093_CR66","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0959-8049(00)00065-4","volume":"36","author":"AR Aro","year":"2000","unstructured":"Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJ. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. Eur J Cancer. 2000;36(9):1089\u201397.","journal-title":"Eur J Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01093-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01093-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01093-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:03:20Z","timestamp":1792425800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01093-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01093-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"144"}}